Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.
作者信息
Baum M
出版信息
Br J Cancer. 1984 Feb;49(2):117-22. doi: 10.1038/bjc.1984.22.
Abstract
摘要
相似文献
1
Prospects for the future in the management of carcinoma of the breast: the biological fall out from clinical trials.乳腺癌管理的未来前景：临床试验带来的生物学影响
Br J Cancer. 1984 Feb;49(2):117-22. doi: 10.1038/bjc.1984.22.
2
Adjuvant chemoendocrine therapy in breast cancer.
J Clin Oncol. 1986 Apr;4(4):451-4. doi: 10.1200/JCO.1986.4.4.451.
3
Management of breast cancer with hormones and drugs.
Hosp Pract (Off Ed). 1986 May 15;21(5):119-27, 131.
4
Current controversies in breast cancer management.
Curr Probl Surg. 1999 Mar;36(3):163-216.
5
Adjuvant systemic therapy in primary breast cancer.原发性乳腺癌的辅助性全身治疗。
Acta Chir Scand Suppl. 1984;519:43-53.
6
The nature of tamoxifen action in the control of female breast cancer.他莫昔芬在女性乳腺癌控制中的作用本质。
In Vivo. 2001 Jul-Aug;15(4):319-25.
7
8
Breast cancer in the elderly.老年乳腺癌
Bull N Y Acad Med. 1992 Nov;68(4):476-82.
9
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.
10
[Hormone therapy of patients with breast cancer].[乳腺癌患者的激素治疗]
Vopr Onkol. 1984;30(11):3-9.
引用本文的文献
1
Six-year results of a controlled trial of tamoxifen as single adjuvant agent in management of early breast cancer.
World J Surg. 1985 Oct;9(5):756-64. doi: 10.1007/BF01655191.
2
Skeletal effects of carcinoma of the breast and prostate.乳腺癌和前列腺癌的骨骼影响。
Ann R Coll Surg Engl. 1986 Sep;68(5):267-70.
3
Progress in understanding breast cancer: epidemiological and biological interactions.乳腺癌研究进展：流行病学与生物学的相互作用
Breast Cancer Res Treat. 1988 May;11(2):91-112. doi: 10.1007/BF01805834.
本文引用的文献
1
THE SIGNIFICANCE OF REGIONAL LUMPH NODE METASTASES IN BREAST CARCINOMA.乳腺癌区域淋巴结转移的意义
Can Med Assoc J. 1965 Aug 14;93(7):289-93.
2
Dose-response effect of adjuvant chemotherapy in breast cancer.辅助化疗在乳腺癌中的剂量反应效应。
N Engl J Med. 1981 Jan 1;304(1):10-5. doi: 10.1056/NEJM198101013040103.
3
Platelet-dependent stimulation of prostacyclin synthesis by platelet-derived growth factor.血小板衍生生长因子对前列环素合成的血小板依赖性刺激作用。
Nature. 1980 Dec 11;288(5791):600-2. doi: 10.1038/288600a0.
4
The contribution of recent NSABP clinical trials of primary breast cancer therapy to an understanding of tumor biology--an overview of findings.近期NSABP原发性乳腺癌治疗临床试验对肿瘤生物学理解的贡献——研究结果概述
Cancer. 1980 Aug 15;46(4 Suppl):1009-25. doi: 10.1002/1097-0142(19800815)46:4+<1009::aid-cncr2820461326>3.0.co;2-h.
5
An antiestrogen-binding protein in human tissues.人类组织中的一种抗雌激素结合蛋白。
J Biol Chem. 1983 Mar 10;258(5):3173-7.
6
Breast cancer, its recurrence, and patient survival in relation to tumor prostaglandins.乳腺癌及其复发和患者生存率与肿瘤前列腺素的关系。
Adv Prostaglandin Thromboxane Leukot Res. 1983;12:299-302.
7
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer.早期乳腺癌乳房切除术后接受辅助性他莫昔芬治疗的患者生存率提高。
Lancet. 1983 Aug 20;2(8347):450. doi: 10.1016/s0140-6736(83)90406-3.
8
Macrophage production by the bone marrow of tumor-bearing mice.荷瘤小鼠骨髓巨噬细胞的生成
Cancer Res. 1972 Dec;32(12):2813-7.
9
Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replication.
Cancer. 1977 Nov;40(5):2290-8. doi: 10.1002/1097-0142(197711)40:5<2290::aid-cncr2820400541>3.0.co;2-t.
10
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design.需要对每位患者进行长期观察的随机临床试验的设计与分析。I. 引言与设计。
Br J Cancer. 1976 Dec;34(6):585-612. doi: 10.1038/bjc.1976.220.
Zotero 插件